GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous ...

Senseonics Holdings (SENS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...

Senseonics Holdings SENS shares soared 5.3% in the last trading session to close at $7.33. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Senseonics (SENS) Holdings has entered into a definitive agreement for the purchase and sale of 45,714,286 shares of its common stock at an offering price of $0.35 per share of common stock in a ...

Detailed price information for Senseonics Holdings Inc (SENS-Q) from The Globe and Mail including charting and trades.

EmblemHealth coverage decision adds nearly 2.9 million covered lives for Eversense CGM “We are excited to see additional coverage for Eversense and appreciate the payer community’s recognition that ...

GERMANTOWN, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, ...